Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors.
about
Placental transfer of antidepressant medications: implications for postnatal adaptation syndromePrenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy.A tale of 2s: optimizing maternal-child health in the context of antenatal maternal depression and antidepressant use.
P2860
Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors.
@en
type
label
Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors.
@en
prefLabel
Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors.
@en
P2860
P1476
Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors
@en
P2093
Alison K Shea
P2860
P304
P356
10.1177/070674371205700902
P407
P577
2012-09-01T00:00:00Z